MedPath
TGA Approval

JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial (352631)

352631

JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial

GlaxoSmithKline Australia Pty Ltd

February 17, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0c3ffd25f04e1d57df2f019345d04e81.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/210899dffbd7a2f50531a6412a0408c9.pdf

Active Ingredients

dostarlimab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.